Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Kit Check Hires New Chief Financial Officer
Kit Check, the leader in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient […]
Bayer Announces Changes in Executive Leadership Team of Crop Science Division
Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
Genome and Company Announces Clinical Trial Collaboration with MSD to Evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in Phase 2 Clinical Trial in Biliary Tract Cancer Patients
Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug […]
Lynx Introduces Modern FinTech to Healthcare—Launches with $17.5M in Funding
Lynx, the leading API-connected healthcare payments, banking, and e-commerce platform, announced today that it has emerged […]
Juli Secures $3.8 Million for AI-powered Platform to Help Manage Chronic Conditions
juli, the AI-powered digital health platform empowering patients and their care teams to manage complex […]
Owkin Welcomes Leading Immuno-oncology Professor as Chief Medical Officer and Senior Pharma Exec as SVP Data Science
Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data […]
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve […]
Seegene Appoints Richard Creager as CEO of U.S. Subsidiary to Bolster U.S. Business
Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Richard S. Creager, Ph.D., […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more